Skip to main content

An independent, nonpartisan information resource — not affiliated with the U.S. government or any campaign.

Wyden Amdt. No. 5336

April 23, 2026 · On the Amendment

Fetterman voted: Yea

Senator John Fetterman voted Yea on this measure. On this vote, Fetterman voted with the majority of the Senate Democratic caucus. The final result was Amendment Rejected (48–50).

What this vote was about

To establish a deficit-neutral reserve fund relating to requiring the Comptroller General of the United States to conduct a study related to economic consequences of private or confidential drug pricing agreements struck by any Federal department, agency, or office with any pharmaceutical manufacturer.

How the parties split

CaucusYeaNay
Democrats440
Republicans250
Independents20

Primary source

U.S. Senate Roll Call Vote — 119th Congress, Session 2, Vote No. 103.

View the official record on Senate.gov →

Questions & answers

How did Fetterman vote on Wyden Amdt. No. 5336?
Senator John Fetterman voted Yea on Wyden Amdt. No. 5336 on April 23, 2026. The measure’s outcome was: Amendment Rejected.
Did Fetterman vote with his party on this?
Yes. On this vote Fetterman voted with the majority of Senate Democrats.

Related Procedural & other votes votes